Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)
China flag China · Delayed Price · Currency is CNY
6.44
+0.03 (0.47%)
Sep 30, 2026, 4:00 PM EDT

SHA:688189 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-134.06-136.9-346.51-10.87-78.83-161.88
Depreciation & Amortization
31.135.0238.1537.2247.8937.66
Other Amortization
1.420.960.710.360.551.3
Loss (Gain) From Sale of Assets
-2.53-2.53-0.59-0.17--
Asset Writedown & Restructuring Costs
34.6234.6231.98-2.7416.72
Loss (Gain) From Sale of Investments
-0.28--14.915.63-3.33
Provision & Write-off of Bad Debts
10.6815.21260.287.11106.17112.04
Other Operating Activities
-3.54-2.33-24.1224.1321.29-0.16
Change in Accounts Receivable
64.58178.3277.4789.27-240.57-141.31
Change in Inventory
21.6228.16-29.633.0924.57-12.45
Change in Accounts Payable
-42.54-76.05-11.9-26.61-67.52126.47
Change in Other Net Operating Assets
22.8722.87----
Operating Cash Flow
20.74114.571.39215.23-160.09-63.11
Operating Cash Flow Growth
-3.57%8121.96%-99.35%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-33.82-79.8-58.43-31.49-41.01-113.59
Sale of Property, Plant & Equipment
1.624.561.880.06--
Investment in Securities
120-100-100.46-660
Other Investing Activities
--0.85-212.37-194.11
Investing Cash Flow
87.8-75.2444.31-131.89171.37352.3

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-10119300490-
Long-Term Debt Issued
-0.03100138.8-465
Total Debt Issued
60.0310.03219438.8490465
Short-Term Debt Repaid
--219-323.8-653.78-500.85-
Long-Term Debt Repaid
-----1.26-261.46
Lease Payments
0.26----1.26-1.07
Total Debt Repaid
-148.74-219-323.8-653.78-502.11-261.46
Net Debt Issued (Repaid)
-88.72-208.97-104.8-214.98-12.11203.54
Repurchase of Common Stock
-18.03-16.14-10---
Common Dividends Paid
-2.8-2.71-5.23-15.82-16.36-56.31
Other Financing Activities
21.03-5.412.86-4.28--5.1
Financing Cash Flow
-88.51-233.23-117.16-235.08-28.47142.13

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
20.03-193.9-71.46-151.74-17.2431.32

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-13.0834.77-57.03183.74-201.1-176.7
Free Cash Flow Growth
------
Free Cash Flow Margin
-9.61%24.50%-22.66%25.52%-28.78%-23.76%
Free Cash Flow Per Share
-0.050.13-0.210.67-0.73-0.64
Levered Free Cash Flow
2.7543.1194.18172.15-102.39-211.36
Unlevered Free Cash Flow
4.1545.3597.55181.68-88.61-199.44
Free Cash Flow After Leases
-12.8234.77-57.03183.74-202.35-177.77

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
7.668.6440.6989.0276.8494.19
Change in Working Capital
83.31170.5141.5662.55-265.52-65.46